Kyntra Bio (KYNB) Assets Average (2015 - 2026)

Kyntra Bio has disclosed Assets Average across 12 years of filings, most recently posting $105.4 million for Q2 2026.

• In Q2 2026, Assets Average fell 38.62% year-over-year to $105.4 million; the TTM figure through Jun 2026 stood at $105.4 million (down 38.62% YoY), while the FY2025 annual figure was $167.1 million, down 47.63% from the prior year.
• Assets Average came in at $105.4 million for Q2 2026 at Kyntra Bio, down from $114.6 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $759.9 million in Q1 2022 to a low of $105.4 million in Q2 2026.
• Average Assets Average over 5 years is $381.9 million, with a median of $362.1 million recorded in 2024.
• Year-over-year, Assets Average dropped 5.85% in 2022 and slumped 51.9% in 2025.
• Over 5 years, Assets Average stood at $609.5 million in 2022, then fell by 27.48% to $442.0 million in 2023, then tumbled by 45.82% to $239.5 million in 2024, then tumbled by 46.42% to $128.3 million in 2025, then fell by 17.89% to $105.4 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $105.4 million in Q2 2026, $114.6 million in Q1 2026, and $128.3 million in Q4 2025.